Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China · Delayed Price · Currency is CNY 5.74
-0.02 (-0.35%)
Feb 4, 2026, 10:15 AM CST
SHE:300158 Revenue
Shanxi Zhendong Pharmaceutical Co.,Ltd had revenue of 757.57M CNY in the quarter ending September 30, 2025, a decrease of -0.69%. This brings the company's revenue in the last twelve months to 2.92B, down -6.28% year-over-year. In the year 2024, Shanxi Zhendong Pharmaceutical Co.,Ltd had annual revenue of 2.97B, down -18.06%.
Revenue (ttm)
2.92B
Revenue Growth
-6.28%
P/S Ratio
1.96
Revenue / Employee
783.93K
Employees
3,720
Market Cap
5.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.97B | -654.89M | -18.06% |
| Dec 31, 2023 | 3.63B | -102.54M | -2.75% |
| Jan 1, 2023 | 3.73B | -1.37B | -26.80% |
| Jan 1, 2022 | 5.09B | 245.94M | 5.07% |
| Dec 31, 2020 | 4.85B | 449.08M | 10.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guizhou Bailing Group Pharmaceutical | 3.15B |
| Jiangsu Lianhuan Pharmaceutical | 2.60B |
| Hunan Warrant Pharmaceutical Co.,Ltd | 1.43B |
| Tianjin Lisheng Pharmaceutical | 1.32B |
| Bide Pharmatech | 1.27B |
| Beijing Beilu Pharmaceutical | 1.13B |
| Jiangsu Jibeier Pharmaceutical | 957.76M |
| Teyi Pharmaceutical Group Co.,Ltd | 924.04M |